Billel Gasmi

12.7k total citations · 2 hit papers
23 papers, 1.2k citations indexed

About

Billel Gasmi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Billel Gasmi has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Billel Gasmi's work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Billel Gasmi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Billel Gasmi collaborates with scholars based in United States, South Korea and United Kingdom. Billel Gasmi's co-authors include Taha Merghoub, Jedd D. Wolchok, Rikke Holmgaard, Yanyun Li, David E. Kleiner, Dmitriy Zamarin, David H. Munn, James P. Allison, Xingchen Mai and David M. Charytan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Billel Gasmi

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series

2020 373 citations Amy Rapkiewicz, Xingchen Mai et al. EClinicalMedicine profile →
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner

2015 371 citations Rikke Holmgaard, Dmitriy Zamarin et al. Cell Reports profile →

Peers

Billel Gasmi

ONCOL

IMMUN

NEURO

Hideko Nakahara Japan

Yaning Yang China

Naomi I. Maria Netherlands

Jun Deng China

Joshua Gustine United States

Michael Schleuning Germany

Mikaël Roussel France

Denis Comte Switzerland

Mathias Grünke Germany

Motoo Nomura Japan

Hideko Nakahara Japan

Billel Gasmi

277 ×0.5

ONCOL

330 ×0.7

IMMUN

117 ×0.4

227 ×1.3

97 ×0.6

NEURO

Citations per year, relative to Billel Gasmi Billel Gasmi (= 1×) peers Hideko Nakahara

Countries citing papers authored by Billel Gasmi

Since Specialization

Citations

This map shows the geographic impact of Billel Gasmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billel Gasmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billel Gasmi more than expected).

Fields of papers citing papers by Billel Gasmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Billel Gasmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billel Gasmi. The network helps show where Billel Gasmi may publish in the future.

Co-authorship network of co-authors of Billel Gasmi

This figure shows the co-authorship network connecting the top 25 collaborators of Billel Gasmi. A scholar is included among the top collaborators of Billel Gasmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Billel Gasmi. Billel Gasmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nah, Shirley, A. Gustafson, Billel Gasmi, et al.. (2025). Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma. Journal of Clinical Oncology. 43(22). 2479–2489.

Leko, Vid, Eric Groh, Shoshana T. Levi, et al.. (2025). Utilization of primary tumor samples for cancer neoantigen discovery. Journal for ImmunoTherapy of Cancer. 13(1). e010993–e010993.

Robinson, Welles, Joshua K. Stone, Fiorella Schischlik, et al.. (2024). Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes. Science Advances. 10(27). eadj7402–eadj7402. 10 indexed citations

Pérez, Paola, Ahmed S. Sultan, Timothy F. Meiller, et al.. (2024). SARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis. PLoS Pathogens. 20(12). e1012375–e1012375. 4 indexed citations

Derkach, Andriy, Billel Gasmi, Theodora Anagnostou, et al.. (2023). T-Cell Exhaustion Signature Predicts Early Relapse after Autologous Stem Cell Transplant for Multiple Myeloma: BMT CTN 0702 Secondary Immune Analysis. Blood. 142(Supplement 1). 3326–3326. 1 indexed citations

Green, Benjamin L., Lauren A. Gamble, Laurence P. Diggs, et al.. (2023). Early Immune Changes Support Signet Ring Cell Dormancy in CDH1 -Driven Hereditary Diffuse Gastric Carcinogenesis. Molecular Cancer Research. 21(12). 1356–1365. 4 indexed citations

Sindiri, Sivasish, Victoria Hill, Billel Gasmi, et al.. (2023). Specific recognition of an FGFR2 fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma. Journal for ImmunoTherapy of Cancer. 11(4). e006303–e006303. 2 indexed citations

Parikh, Anup Y., Billel Gasmi, Ken‐ichi Hanada, et al.. (2023). Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens. Cancer Immunology Immunotherapy. 72(10). 3149–3162. 21 indexed citations

Türkbey, Barış, Billel Gasmi, Keith T. Schmidt, et al.. (2021). Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers. Scientific Reports. 11(1). 5662–5662. 2 indexed citations

10.

Xie, Changqing, Austin G. Duffy, Gagandeep Brar, et al.. (2020). Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 26(10). 2318–2326. 65 indexed citations

11.

Rapkiewicz, Amy, Xingchen Mai, Steven E. Carsons, et al.. (2020). Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine. 24. 100434–100434. 373 indexed citations breakdown →

12.

Gasmi, Billel, et al.. (2020). Hepatocellular Carcinoma Where You Least Expect It. The American Journal of Gastroenterology. 115(7). 1134–1136. 1 indexed citations

13.

Gasmi, Billel & David E. Kleiner. (2019). Liver Histology. Clinics in Liver Disease. 24(1). 61–74. 30 indexed citations

14.

Trindade, Christopher, Elizabeth McDonough, Jeffrey Hanson, et al.. (2019). Utilization of novel highly multiplexed immunofluorescence microscopy technology to understand immunological tumor microenvironments in small cell lung carcinoma patients receiving combination PD-L1 and PARP inhibition therapy.. Journal of Clinical Oncology. 37(15_suppl). e14289–e14289. 1 indexed citations

15.

Zappasodi, Roberta, Sadna Budhu, Matthew D. Hellmann, et al.. (2018). Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity. Cancer Cell. 33(6). 1017–1032.e7. 113 indexed citations

16.

Hirschhorn, Daniel, Jacob Ricca, Billel Gasmi, et al.. (2018). A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation. The Journal of Immunology. 200(Supplement_1). 178.42–178.42. 4 indexed citations

17.

Momtaz, Parisa, Elena Pentsova, Omar Abdel‐Wahab, et al.. (2016). Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies. Oncotarget. 7(51). 85430–85436. 52 indexed citations

18.

Holmgaard, Rikke, Billel Gasmi, David R. Jones, et al.. (2016). Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy. OncoImmunology. 5(7). e1151595–e1151595. 55 indexed citations

19.

Holmgaard, Rikke, Dmitriy Zamarin, Yanyun Li, et al.. (2015). Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner. Cell Reports. 13(2). 412–424. 371 indexed citations breakdown →

20.

Khalil, Danny N., Sadna Budhu, Billel Gasmi, et al.. (2015). The New Era of Cancer Immunotherapy. Advances in cancer research. 128. 1–68. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact